Ipratropium induced bronchoconstriction in a young Asthmatic: A case report

Article Sidebar

PDF HTML
Submitted: January 15 2021
Published: Feb 23, 2021
DOI: 10.29328/journal.acr.1001046

Main Article Content

H Aleshaa*
Department of Child Health, National Health Service (NHS), UK
J Collindridge
Department of Child Health, National Health Service (NHS), UK
RK Singh
Department of Child Health, National Health Service (NHS), UK

Article Details

Aleshaa, H., Collindridge, J., & Singh, R. (2021). Ipratropium induced bronchoconstriction in a young Asthmatic: A case report. Archives of Case Reports, 5(1), 007–008. https://doi.org/10.29328/journal.acr.1001046
Case Reports

Copyright (c) 2021 Aleshaa H, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

British Thoracic Society and Scottish intercollegiate guidelines Network. British guideline on the management of asthma. Thorax . 2008; 63 Suppl 4: 1-121. PubMed: https://pubmed.ncbi.nlm.nih.gov/18463203/

Baeza-Trinidad R, Mosquera-Lozano JD. Acute coronary syndrome secondary to paradoxical bronchospasm due to nebulized ipratropium bromide. Clin Case Rep Rev. 2017.

Magee JS, Pittman LM, Jette-Kelly LA. Paradoxical Bronchoconstriction with Short-Acting Beta Agonist. Am J Case Rep. 2018; 19: 1204-1207. PubMed: https://pubmed.ncbi.nlm.nih.gov/30297688/

Mutlu GM, Moonjelly E, Chan L, Olopade CO. Laryngospasm and paradoxical bronchoconstriction after repeated doses of ?2-agonists containing edetate disodium. Mayo Clin Proc. 2000; 75: 285-287. PubMed: https://pubmed.ncbi.nlm.nih.gov/10725956/

Jayaraman D, Brar K. A Case of ipratropium bromide allergy in a patient with severe persistent asthma. Annals of Allergy, Asthma & Immunology. 2016.

Committtee J. formulary. British national formulary for children. BMJ Publishing and the Royal Pharmaceutical Society. 2020.

BCD. Atrovent® 250 UDVs®, 1 ml (Ipratropium bromide). 2020. www.medicines.org.uk/emc/product/3818/smpc